Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer (SCLC): GOIRC-AIFA FARM6PMFJM trialMarcello Tiseo, Andrea Ardizzoni, Francesca Ambrosio et al.|Annals of Oncology|2016Cited by 2